FSD: Advancing Research and Development
FSD's R&D platform focuses on cannabinoids and their potential for widespread clinical applications. With the acquisition of Prismic Pharmaceuticals, …
Advancing R&D to fulfill unmet medical needs.
FSD's R&D platform focuses on cannabinoids and their potential for widespread clinical applications. With the acquisition of Prismic Pharmaceuticals, they have added an R&D platform with the capability of producing synthetic cannabinoids and opioid sparing compounds that would hopefully gain FDA approval to commercialize prescription medications in United States, Canada & ROW.
About FSD Pharma
FSD Pharma is a broadly diversified cannabis company with operations including research and development, cultivation, processing, extraction, and manufacturing.
They have a ‘farm to laboratory’ vertically-integrated operating structure. The farming operation produces raw materials for cannabis products and derivatives. They achieve this through a highly-managed supply chain process which aim to yield maximum, high-quality product efficiently.
Moreover, they're focusing on the development of the highest quality indoor grown, pharmaceutical grade cannabis. Additionally, they do research and development of novel cannabinoid-based treatments for for better patient outcome.
For more information on FSD Pharma (HUGE:CSE) please fill out the form below.
Latest Articles
Hot Companies
You might also like
Volta Metals: Powering the Future with Ontario’s Critical Minerals
As global demand for critical minerals surges, Volta Metals is strategically positioned in Northwestern Ontario, exploring lithium and rare metals in proximity to infrastructure and clean energy sources.
.png)
.png)
